Following kidney removal, the remaining kidney enlarges and increases its function. The mechanism and signals driving this compensatory kidney hypertrophy and the enlargement of its constituent kidney cells remains elusive. RNA-seq studies in mice undergoing hypertrophy 24, 48, and 72 h following nephrectomy were undertaken to understand the early transcriptional changes. This revealed substantial enhancement of cholesterol biosynthesis pathways, increases in mitochondrial gene expression and cell cycle perturbations. Single nuclei RNA-seq delineated cell specific changes at 24 h post nephrectomy and showed that sterol binding protein 2 (SREBP2) activity increases in medullary thick ascending limb cells in keeping with promotion of cholesterol synthesis. Cultured renal tubular cells were examined for insulin-like growth factor-1 (IGF-1) stimulated hypertrophy and SREBP2 was found to be required for increase in cell size. This work describes the early cell specific growth pathways mediating cellular and kidney hypertrophy with an intriguing role for cholesterol synthesis.
Keyphrases
- single cell
- rna seq
- gene expression
- induced apoptosis
- cell cycle
- cell cycle arrest
- binding protein
- cell therapy
- oxidative stress
- cell proliferation
- cell death
- stem cells
- endoplasmic reticulum stress
- metabolic syndrome
- pulmonary hypertension
- coronary artery
- type diabetes
- skeletal muscle
- pulmonary artery
- insulin resistance
- transcription factor
- heat shock protein
- growth hormone
- robot assisted